「th」の検索結果
184件：91～95件目を表示
-
h 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Sh...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
ida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential c...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
お知らせ | 千寿製薬株式会社
2026年06月01日 Launch of Distribution of 3in1Smart and SPM-700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF...
https://www.senju.co.jp/chinese/news/ -
Sales Trends and Breakdown | About Senju | SENJU Pharmaceutical
Company Profile Milestones in Our History
https://www.senju.co.jp/english/about/sales.html -
千寿製薬株式会社
2026年06月01日 Launch of Distribution of 3in1Smart and SPM-700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF...
https://www.senju.co.jp/chinese/